TrialBMC medicine2017

Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial.

Jona Walk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.